- Navigating Your Midlife Crisis: Embracing New Possibilities
- City Raccoons Showing Signs of Domestication
- Mapping the Exposome: Science Broadens Focus to Environmental Disease Triggers
- One Week Less on Social Media Linked to Better Mental Health
- Your Brain Changes in Stages as You Age, Study Finds
- Some Suicide Victims Show No Typical Warning Signs, Study Finds
- ByHeart Formula Faces Lawsuits After Babies Sickened With Botulism
- Switch to Vegan Diet Could Cut Your Greenhouse Gas Emissions in Half
- Regular Bedtime Does Wonders for Blood Pressure
- Dining Alone Could Mean Worse Nutrition for Seniors
Hormone Therapy For Menopause Linked To Alzheimer’s Hallmark
Hormone replacement therapy during menopause appears to be linked to a toxic brain protein that’s a hallmark of Alzheimer’s disease.
Women over 70 had a faster accumulation of tau in their brains if they’d taken hormone therapy for menopause symptoms more than a decade before, according to a new report in Science Advances.
Tau tangles are one of the hallmarks associated with Alzheimer’s, researchers noted.
Researchers did not find a significant difference in their accumulation of amyloid beta, another toxic protein linked to Alzheimer’s.
“Approximately a quarter of currently postmenopausal women who are 70 years and older have a history of HT use and have now entered a critical age of risk for Alzheimer’s disease,” senior researcher Rachel Buckley, a cognitive neuroscientist with Massachusetts General Hospital in Boston, said in a news release.
But researchers found that hormone therapy among younger women did not appear to be linked with increased tau accumulations — supporting the notion that it should be safe early in menopause.
“Our findings add to the evidence that delaying initiation of hormone therapy, especially in older women, could lead to worse Alzheimer’s outcomes,” Buckley said.
For the study, researchers compared brain imaging from 73 women who’d used hormone therapy an average of 14 years earlier with 73 age-matched women who had not.
The participants underwent PET scans for amyloid beta over an average 4.5 years, and for tau an average 3.5 years.
Women 70 or older who used hormone therapy showed faster tau accumulation in specific regions of their brain, results show.
“Our data indicate that hormone therapy may influence tau accumulation as a function of age, with implications for cognitive decline,” lead researcher Gillian Coughlan with Massachusetts General Hospital said in a news release.
“We hope that our study will help to inform Alzheimer’s disease risk discussions relating to women’s reproductive health and treatment,” Coughlan added.
More information
The American College of Obstetricians and Gynecologists has more on hormone therapy for menopause.
SOURCE: Mass General Brigham, news release, March 5, 2025
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.










